![](/img/cover-not-exists.png)
5.16 A Phase 2 Randomized, Placebo-Controlled Trial of Tideglusib, an Orally Administered GSK-3 Beta Inhibitor, in the Treatment of Adolescents With ASD
Anagnostou, Evdokia, Bennett, Teresa Ann, Thorpe, Kevin, Nicolson, RobVolume:
57
Language:
english
Journal:
Journal of the American Academy of Child & Adolescent Psychiatry
DOI:
10.1016/j.jaac.2018.09.311
Date:
October, 2018
File:
PDF, 123 KB
english, 2018